Concordis Group Incorporated
CNGI · OTC
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | 0.01 | -0.22 | -0.01 |
| FCF Yield | 480.91% | 459.80% | 132.89% | 902.55% |
| EV / EBITDA | 8.40 | -27.81 | 53.78 | 14.67 |
| Quality | ||||
| ROIC | 2.29% | -1.09% | 0.76% | 0.71% |
| Gross Margin | 40.09% | -1.86% | 30.33% | 42.84% |
| Cash Conversion Ratio | 197.34 | -913.23 | 33.52 | -67.93 |
| Growth | ||||
| Revenue 3-Year CAGR | 44.67% | 36.19% | 11.18% | -19.93% |
| Free Cash Flow Growth | 4.59% | 31.81% | -85.28% | 1.05% |
| Safety | ||||
| Net Debt / EBITDA | 2.15 | -8.28 | 6.48 | 1.22 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 2.09 | 1.60 | 1.26 | 1.82 |
| Cash Conversion Cycle | 735.63 | 1,646.15 | 1,050.82 | 4,081.76 |